Funding Opportunity PAR-22-204 from the NIH Guide for Grants and Contracts. The Office of Research Infrastructure Programs (ORIP) encourages grant applications aimed at developing, characterizing, or improving animal models for HIV/AIDS research or for improving access to information about or generated from the use of these specialized animal models for such research. The animal models, related biological materials, or technological tools to be developed must be broadly applicable to the scientific interests of two or more NIH Institutes or Centers (ICs) and must explore multiple body systems or evaluate diseases and processes that impact multiple body systems in order to align with ORIPs NIH-wide mission and programs as well as the research priorities of NIH Office of AIDS Research. Applications must describe the need for and the potential impact of the proposed resources on HIV/AIDS research. Applications for developing a limited number of resources or resources that will not have a broad impact on HIV/AIDS research will not be considered acceptable for this Funding Opportunity Announcement.

Notice NOT-OD-22-203 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-22-230 from the NIH Guide for Grants and Contracts. This funding announcement solicits R01 grant applications that propose independent research projects that are consistent with the scientific framework detailed in the 2022-2026 National Institute of Nursing Research (NINR) Strategic Plan. This research will be rooted in nursing's holistic, contextualized approach to understanding people and their health, address the nation's most pressing and persistent health challenges with a solutions orientation, and employ innovative and rigorous study designs to inform practice and policy.

Funding Opportunity PAR-22-231 from the NIH Guide for Grants and Contracts. This funding announcement solicits R21 grant applications that propose exploratory/developmental research projects that are consistent with the research framework detailed in the 2022-2026 National Institute of Nursing Research (NINR) Strategic Plan. This research will be rooted in nursing's holistic, contextualized approach to understanding people and their health, address the nation's most pressing and persistent health challenges with a solutions orientation, and employ innovative and rigorous study designs to inform practice and policy.

Notice NOT-AG-22-033 from the NIH Guide for Grants and Contracts

Notice NOT-AG-22-034 from the NIH Guide for Grants and Contracts

Notice NOT-AG-22-035 from the NIH Guide for Grants and Contracts

Notice NOT-AG-22-036 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-22-243 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement is to encourage collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution of a biomedical problem; and 2) integrate, optimize, validate, translate or otherwise accelerate the adoption of promising tools, methods, and techniques for a specific research or clinical problem in basic, translational, or clinical science and practice. An application may propose design-directed, developmental, discovery-driven, or hypothesis-driven research and is appropriate for small teams applying an integrative approach to increase our understanding of and solve problems in biological, clinical, or translational science.

Funding Opportunity PAR-22-242 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement is to encourage collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution of a biomedical problem; and 2) integrate, optimize, validate, translate or otherwise accelerate the adoption of promising tools, methods, and techniques for a specific research or clinical problem in basic, translational, or clinical science and practice. An application may propose design-directed, developmental, discovery-driven, or hypothesis-driven research and is appropriate for small teams applying an integrative approach to increase our understanding of and solve problems in biological, clinical, or translational science.

Notice NOT-OD-22-209 from the NIH Guide for Grants and Contracts

Notice NOT-ES-22-013 from the NIH Guide for Grants and Contracts

Notice NOT-AT-22-031 from the NIH Guide for Grants and Contracts

Notice NOT-HD-22-044 from the NIH Guide for Grants and Contracts

Notice NOT-TW-22-005 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DA-23-037 from the NIH Guide for Grants and Contracts. The FOA is expected to be published in early 2022 with an expected application due date in Fall 2022. (from NOT-DA-21-085, TJZ 3/11/2022).

Notice NOT-AT-22-030 from the NIH Guide for Grants and Contracts

Notice NOT-OD-22-208 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HG-22-010 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to establish a Data Analysis and Coordination Center (DACC) that will be part of a collaborative initiative to advance the application of multi-omic technologies to study health and disease in diverse populations. Together with the Disease Study Sites (RFA-HG-22-008) and the Omics Production Center(s) (RFA-HG-22-009), the DACC will leverage clinical conditions where multi-omic approaches are expected to be most informative to: 1) explore the use of multi-omics, integrated with phenotypic and environmental exposure data, including social determinants of health (SDOH), to detect and assess molecular profiles associated with healthy and disease states; 2) develop generalizable data harmonization, integration, and analysis methods, as well as best practices and standards for the optimal application of multi-omics; and 3) create a multi-dimensional dataset that is available to the research community. The DACC will be primarily responsible for coordinating Consortium logistics, outreach, and dissemination of findings; for managing and securing Consortium data; for creating the multi-dimensional dataset; and for coordinating and contributing to consortium-wide protocol development, data analysis, and methods development efforts. While this program may provide some insights into disease etiology, its primary goal is to validate and enhance generalizable multi-omic approaches to identify meaningful biological changes related to health and disease.

Funding Opportunity RFA-HG-22-009 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to establish Omics Production Center(s) (OPC(s)) that will be part of a collaborative initiative to advance the application of multi-omic technologies to study health and disease in diverse populations. Together with the Disease Study Sites (RFA-HG-22-008) and the Data Analysis and Coordination Center (RFA-HG-22-010), the Omics Production Center(s) will leverage clinical conditions where multi-omic approaches are expected to be most informative to: 1) explore the use of multi-omics, integrated with phenotypic and environmental exposure data, including social determinants of health (SDOH), to detect and assess molecular profiles associated with healthy and disease states; 2) develop generalizable data harmonization, integration, and analysis methods, as well as best practices and standards for the optimal application of multi-omics; and 3) create a multi-dimensional dataset that is available to the research community. The OPC(s) will be primarily responsible for using high high-throughput molecular assays to produce omics data from the biosamples provided by the Disease Study Sites (DSS, RFA-HG-22-008) and contributing to consortium-wide protocol development, data analysis, methods development, and the production of the multi-dimensional dataset. While this program may provide some insights into disease etiology, its primary goal is to validate and enhance generalizable multi-omic approaches to identify meaningful biological changes related to health and disease.